Lifshitz Law PLLC Announces Investigations of Replimune Group, Inc. (NASDAQ: REPL), Datavault AI Inc. (NASDAQ: DVLT), Blaize Holdings, Inc. (NASDAQ: BZAI), and ARS Pharmaceuticals (NASDAQ: SPRY)
NEW YORK CITY, NY / ACCESS Newswire / October 27, 2026 /Lifshitz Law Firm
Replimune Group, Inc. (NASDAQ:REPL)
Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) in connection with the Biologics License Application ("BLA"), the study design concerns previously communicated by the FDA were not addressed; (ii) Replimune had submitted data from an early unplanned analysis from RP1-104, which included only 40 patients (10% of the planned enrollment of 400 patients); and (iii) as a result, RPL-001-16 and RP1-104 both had deficiencies which were likely to cause the FDA to reject the BLA.
If you are an REPL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
Datavault AI Inc. (NASDAQ:DVLT)
Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) the Company had overstated the economic value to Datavault AI of its various corporate partnerships with, inter alia, Burke, Scilex, and Nature 's Miracle; (ii) the Company had overstated the volume of trading activity on the Datavault Platform, which was in fact minimal; (iii) Datavault 's undisclosed connections with Edward Withrow III, a convicted felon, when revealed, would cause Datavault AI to incur reputational harm; and (iv) as a result, the Company 's public statements were materially false and misleading at all relevant times.
If you are a DVLT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
Blaize Holdings, Inc. (NASDAQ:BZAI)
Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) Blaize announced transactions with entities wholly unequipped to conduct meaningful business in order to create an appearance of growth; (ii) Blaize improperly recognized revenue; and (iii) as a result, the Company 's public statements were materially false and/or misleading at all relevant times.
If you are a BZAI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
ARS Pharmaceuticals (NASDAQ:SPRY)
Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) the Company provided overwhelmingly positive statements to investors while simultaneously concealing material adverse facts concerning the expected timeline for expanded insurance coverage through CVS Caremark; and (ii) as a result of the foregoing, the Company 's statements regarding ARS Pharmaceuticals ' business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
If you are an SPRY investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
ATTORNEY ADVERTISING.© 2026 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Law PLLC
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@lifshitzlaw.com
SOURCE:Lifshitz Law Firm
View the original press release on ACCESS Newswire
© 2026 ACCESS Newswire. All Rights Reserved.
